Is melatonin protective in contrast material related renal failure?; [Melatonin kontrast madde ile ilişkili renal yetmezlikten korur mu?]
dc.contributor.author | Tuncyurek O. | |
dc.contributor.author | Gunay O. | |
dc.contributor.author | Taneli F. | |
dc.contributor.author | Ayhan S. | |
dc.contributor.author | Nese N. | |
dc.contributor.author | Pabuscu Y. | |
dc.date.accessioned | 2024-07-22T08:14:18Z | |
dc.date.available | 2024-07-22T08:14:18Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Aim: The aim of the study was to investigate the effect of melatonin on the renal injury resulting from radiocontrast media and myoglobinuria in male Wistar albino rats. Material and Method: 50% glycerol at equal amounts was intramuscularly administered to both hind legs of all animals under ether anesthesia at the dose of 10 mg/kg. Three hours later, the groups were ad-ministered the following: Group I (number:7): Iopromide(Ultravist -300®) at the dose of 2 ml/kg (intracardiac); Group II (number:7): Iopromide(Ultravist -300®) and intraperitoneally administered Melatonin at the dose of 10 mg/kg (Melatonin was dissolved in 7.5% absolute ethanol and further dilutions were made in saline.); and Group III (number:7): 2 ml/kg of sterile physiologic saline (Control group). The levels of Uurea, Ccreatinine and Ccystatin C were studied on the blood samples collected. The renal samples were evaluated by 2two distinct pathologists who did not know the protocol. Results: There was no difference in the values of Creatinine and cystatin c between Groups 2 and 3 (p=0.9; 0.2). Discussion: In conclusion, we evaluated the possible prevention of contrast-induced oxidative stress in the kidney with using melatonin. How-ever, additional clinical studies are needed to evaluate the role of preventive melatonin treatment in humans. © 2015, Journal of Clinical and Analytical Medicine. All rights reserved. | |
dc.identifier.DOI-ID | 10.4328/JCAM.1929 | |
dc.identifier.issn | 13090720 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16547 | |
dc.language.iso | English | |
dc.publisher | Journal of Clinical and Analytical Medicine | |
dc.subject | creatinine | |
dc.subject | cystatin C | |
dc.subject | melatonin | |
dc.subject | urea | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | blood sampling | |
dc.subject | contrast induced nephropathy | |
dc.subject | controlled study | |
dc.subject | creatinine blood level | |
dc.subject | drug effect | |
dc.subject | enzyme blood level | |
dc.subject | histopathology | |
dc.subject | male | |
dc.subject | myoglobinuria | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | rat | |
dc.subject | renal protection | |
dc.subject | urea blood level | |
dc.title | Is melatonin protective in contrast material related renal failure?; [Melatonin kontrast madde ile ilişkili renal yetmezlikten korur mu?] | |
dc.type | Article |